Phase 2 Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and teenagers between the ages of 6 and 17
- People who have been diagnosed with asthma within the last 2 years
- People who have either a breath test result showing airway inflammation above a certain level (FeNO greater than 50 ppb), or a confirmed history of environmental allergies shown by a skin prick test or a blood test for allergen sensitivity
- People who have not visited an emergency department in the past month
- People who are able to drink a liquid containing fiber or a placebo (inactive substitute)
- People who are able to return for a follow-up visit 4 to 6 weeks after joining
- People who do not follow a special or restricted diet
Who may not be able to join:
- People who have cystic fibrosis
- People who have bronchiectasis (a long-term lung condition affecting the airways)
- People whose asthma medications (other than quick-relief inhalers) are planned to change during the 4 to 6 week study period
- People whose estimated daily fiber intake is 16 grams or less, as measured by a specific dietary recall tool called the ASA24
- People who have a sibling already enrolled in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthew Rank, Phoenix Children's
Phone: 6029334979
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Alpha diversity.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.